MedCity CONVERGE is an executive-level summit that gathers healthcare leaders from all sectors—health systems, insurers, digital health, medical devices, pharma, entrepreneurs, government leaders, investors, and other key stakeholders—to discuss and discover the latest innovations in healthcare.
This year, the summit tackles one of healthcare’s toughest challenges: cancer.
Held July 31–August 1 in Philadelphia, MedCity CONVERGE 2017 gathers all sectors of the oncology ecosystem to provide the most accurate picture of healthcare innovation in cancer care: where it is right now, where it’s headed, and the best ways to innovate in your organization.
Through a mix of provocative conversations, interactive networking sessions, and a showcase of the hottest early-stage companies, the event will explore how AI, Big Data, and Precision Medicine are changing the game in cancer.
Dr. Carrie Stricker will be participating in a panel session titled “The Davids vs. the Cancer Goliath,” in which participants with hear from eight regional startups ranging from diagnostics, biopharma, and medtech, to emerging tech (AI, VR, Big Data), on how they are taking aim at cancer.
About the Organizer
MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what’s next and what matters with a mix of breaking news and analysis on startups and established industry leaders, personalities, policies, and the most important deals.
One Comment